Abalis Finance AG was established in 2006.

The company was successful Lead- and Co-investor in a number of Grow-Ups in the Life Science Technologies, Pharmaceuticals Industries Solutions, Renewable Energies and Process Equipment and Management.

By End of June 2020, Abalis Finance AG has completed the structured exit process and subsequently ended it’s active role in respective participations

As a consequence, Abalis Finance AG was downsized and Andres Huber and Andreas Miescher have left the Board.